Investigational drug · Phase 2
WAS123
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Schizophenia Disorder.
Phase 2Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
0 still active
All registered trials
1
Any phase or sponsor naming "WAS123"
First trial start
2022
May 10, 2022
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
- EMS1
All registered trials by phase
Every ClinicalTrials.gov drug study naming "WAS123", any sponsor or status.
Conditions studied
As listed on its trial records.
- Schizophenia Disorder
Largest trials
Live from ClinicalTrials.gov: studies naming "WAS123" as an intervention, largest first.
- A Clinical Trial to Compare the Efficacy and Safety of WAS123 Versus Daily Aripiprazole in the Maintenance Treatment of Patients With Schizophrenia.Pivotal-lookingCompleted
EMSIndustry
NCT07843056 · 121 participants · Start May 10, 2022 · Primary completion Jan 20, 2026
Drug: WAS123; Aripiprazole (Fixed dose) · For: Schizophenia Disorder
Sites: São Paulo, Brazil
Newest research
PubMed records naming it or its code names, newest first.
- A study of SGLT2 inhibitors on levels of plasma atherogenesis biomarkers in diabetes.
Nallathambi N, Pratheep V, Adithyan C, et al. · J Family Med Prim Care 2024
- Ventricular vulnerability in diabetes and myocardial norepinephrine release.
Fusilli L, Lyons M, Patel B, et al. · Am J Med Sci 1989
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.